Human Genome Epidemiology Literature Finder
|
Records 1 - 25 (of 25 Records) |
| Query Trace: Breast Neoplasms and IGFBP3[original query] |
|---|
| Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. International journal of cancer. Journal international du cancer 2003 Oct 107 (1): 60-4. Schernhammer Eva S, Hankinson Susan E, Hunter David J, Blouin Marie J, Pollak Michael |
| Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Aug 13 (8): 1290-5. Ren Zefang, Cai Qiuyin, Shu Xiao-Ou, Cai Hui, Li Chun, Yu Herbert, Gao Yu-Tang, Zheng W |
| A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Apr 13 (4): 573-82. Lai Joe H, Vesprini Danny, Zhang William, Yaffe Martin J, Pollak Michael, Narod Steven |
| Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC cancer 2004 Mar 4 (): 9. Sigurdson Alice J, Hauptmann Michael, Chatterjee Nilanjan, Alexander Bruce H, Doody Michele Morin, Rutter Joni L, Struewing Jeffery |
| Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer. Endocrine-related cancer 2005 Dec 12 (4): 917-28. Wagner K, Hemminki K, Israelsson E, Grzybowska E, Klaes R, Chen B, Butkiewicz D, Pamula J, Pekala W, Försti |
| IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human molecular genetics 2006 Jan 15 (1): 1-10. Al-Zahrani Ali, Sandhu Manjinder S, Luben Robert N, Thompson Deborah, Baynes Caroline, Pooley Karen A, Luccarini Craig, Munday Hannah, Perkins Barbara, Smith Paula, Pharoah Paul D P, Wareham Nicholas J, Easton Douglas F, Ponder Bruce A J, Dunning Alison |
| Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Nov 14 (11 Pt 1): 2648-54. Mulhall Cara, Hegele Robert A, Cao Henian, Tritchler David, Yaffe Martin, Boyd Norman |
| Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer causes & control : CCC 2005 Dec 16 (10): 1147-57. Slattery M L, Baumgartner K B, Byers Tim, Guiliano Anna, Sweeney Carol, Herrick Jennifer, Curtin Karen, Murtaugh Maureen, Wolff Rog |
| Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. Journal of the National Cancer Institute 2006 Oct 98 (19): 1382-96. Authors are not available |
| Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Breast cancer research and treatment 2007 Sep 104 (3): 309-19. Deming Sandra L, Ren Zefang, Wen Wanqing, Shu Xiao Ou, Cai Qiuyin, Gao Yu-Tang, Zheng W |
| Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast cancer research and treatment 2007 Aug 104 (2): 197-209. Slattery M L, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, Byers |
| Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 Oct 15 (10): 1993-7. Cheng Iona, Penney Kathryn L, Stram Daniel O, Le Marchand Loic, Giorgi Elena, Haiman Christopher A, Kolonel Laurence N, Pike Malcolm, Hirschhorn Joel, Henderson Brian E, Freedman Matthew |
| Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. British journal of cancer 2006 Jan 94 (2): 299-307. Canzian F, McKay J D, Cleveland R J, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann P H, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita H B, van Gils C H, Peeters P H M, Pera G, Ardanaz E, Chirlaque M-D, Quirós J R, Larrañaga N, Martínez-García C, Allen N E, Key T J, Bingham S A, Khaw K-T, Slimani N, Norat T, Riboli E, Kaaks |
| Mammographic density and candidate gene variants: a twins and sisters study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Jul 16 (7): 1479-84. Stone Jennifer, Gurrin Lyle C, Byrnes Graham B, Schroen Christopher J, Treloar Susan A, Padilla Emma J D, Dite Gillian S, Southey Melissa C, Hayes Vanessa M, Hopper John |
| A common coding variant in CASP8 is associated with breast cancer risk. Nature genetics 2007 Mar 39 (3): 352-8. Cox Angela, Dunning Alison M, Garcia-Closas Montserrat, Balasubramanian Sabapathy, Reed Malcolm W R, Pooley Karen A, Scollen Serena, Baynes Caroline, Ponder Bruce A J, Chanock Stephen, Lissowska Jolanta, Brinton Louise, Peplonska Beata, Southey Melissa C, Hopper John L, McCredie Margaret R E, Giles Graham G, Fletcher Olivia, Johnson Nichola, dos Santos Silva Isabel, Gibson Lorna, Bojesen Stig E, Nordestgaard Børge G, Axelsson Christen K, Torres Diana, Hamann Ute, Justenhoven Christina, Brauch Hiltrud, Chang-Claude Jenny, Kropp Silke, Risch Angela, Wang-Gohrke Shan, Schürmann Peter, Bogdanova Natalia, Dörk Thilo, Fagerholm Rainer, Aaltonen Kirsimari, Blomqvist Carl, Nevanlinna Heli, Seal Sheila, Renwick Anthony, Stratton Michael R, Rahman Nazneen, Sangrajrang Suleeporn, Hughes David, Odefrey Fabrice, Brennan Paul, Spurdle Amanda B, Chenevix-Trench Georgia, , Beesley Jonathan, Mannermaa Arto, Hartikainen Jaana, Kataja Vesa, Kosma Veli-Matti, Couch Fergus J, Olson Janet E, Goode Ellen L, Broeks Annegien, Schmidt Marjanka K, Hogervorst Frans B L, Van't Veer Laura J, Kang Daehee, Yoo Keun-Young, Noh Dong-Young, Ahn Sei-Hyun, Wedrén Sara, Hall Per, Low Yen-Ling, Liu Jianjun, Milne Roger L, Ribas Gloria, Gonzalez-Neira Anna, Benitez Javier, Sigurdson Alice J, Stredrick Denise L, Alexander Bruce H, Struewing Jeffery P, Pharoah Paul D P, Easton Douglas F, |
| IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PloS one 2008 3 (7): e2578. Patel Alpa V, Cheng Iona, Canzian Federico, Le Marchand Loïc, Thun Michael J, Berg Christine D, Buring Julie, Calle Eugenia E, Chanock Stephen, Clavel-Chapelon Francoise, Cox David G, Dorronsoro Miren, Dossus Laure, Haiman Christopher A, Hankinson Susan E, Henderson Brian E, Hoover Robert, Hunter David J, Kaaks Rudolf, Kolonel Laurence N, Kraft Peter, Linseisen Jakob, Lund Eiliv, Manjer Jonas, McCarty Catherine, Peeters Petra H M, Pike Malcolm C, Pollak Michael, Riboli Elio, Stram Daniel O, Tjonneland Anne, Travis Ruth C, Trichopoulos Dimitrios, Tumino Rosario, Yeager Meredith, Ziegler Regina G, Feigelson Heather Spencer, |
| Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast cancer research and treatment 2010 Apr 120 (3): 727-36. Authors are not available |
| IGFBP3 polymorphisms and risk of cancer: a meta-analysis. Molecular biology reports 2010 Jan 37 (1): 127-40. Li Li, Huang Xin, Huo Ke |
| Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC medical genomics 2010 3 (1): 9. Biong Margarethe, Gram Inger T, Brill Ilene, Johansen Fredrik, Solvang Hiroko K, Alnaes Grethe I G, Fagerheim Toril, Bremnes Yngve, Chanock Stephen J, Burdett Laurie, Yeager Meredith, Ursin Giske, Kristensen Vessela |
| Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast cancer research and treatment 2010 Oct 123 (3): 843-55. Taverne Cornelia W, Verheus Martijn, McKay James D, Kaaks Rudolf, Canzian Federico, Grobbee Diederick E, Peeters Petra H M, van Gils Carla |
| IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Breast cancer research and treatment 2011 Jun 127 (3): 785-94. Rosendahl Ann H, Hietala Maria, Henningson Maria, Olsson Håkan, Jernström Hele |
| IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. Breast cancer research and treatment 2010 Aug 122 (3): 867-71. Qiu Li-Xin, Yao Lei, Yuan Hui, Mao Chen, Chen Bo, Zhan Ping, Xue Kai, Zhang Jian, Hu Xi-Ch |
| Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. Cancer science 2011 Nov 102 (11): 2065-72. Yoshimoto Nobuyasu, Nishiyama Takeshi, Toyama Tatsuya, Takahashi Satoru, Shiraki Norio, Sugiura Hiroshi, Endo Yumi, Iwasa Mai, Fujii Yoshitaka, Yamashita Hiro |
| Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. PloS one 2013 8 (6): e65313. Ozhand Ali, Lee Eunjung, Wu Anna H, Ellingjord-Dale Merete, Akslen Lars A, McKean-Cowdin Roberta, Ursin Gis |
| Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2015 Apr 71 108-11. Ma Xiaobin, Kang Huafeng, Dai Zhijun, Ma Li, Jin Yaofeng, Wang Xiji |
- Page last reviewed:Feb 1, 2024
- Content source: